# Paclitaxel

NDC: 0703-3213
Generic name: Paclitaxel
Labeler / Manufacturer: Teva Parenteral Medicines, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20200707

FDA application: ANDA075184

## Active ingredients

- PACLITAXEL: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0703-3213"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0703-3213
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbd32bd2-9685-41cb-bee2-730a45526b65